Avita logo.jpg
AVITA Medical Announces Preliminary Fiscal Second Quarter 2021 Results
January 12, 2021 08:00 ET | AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Jan. 12, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
Avita logo.jpg
AVITA Medical to Present at the J.P. Morgan 39th Annual Healthcare Conference
December 28, 2020 17:00 ET | AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Dec. 28, 2020 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
Avita logo.jpg
RECELL® System Data Presented at American Burn Association Fall Regional Burn Conferences
December 15, 2020 08:00 ET | AVITA Medical
Abstracts Highlighting Clinical and Health Economic Data Reinforce Effectiveness of Treatment with RECELL System More than 10,000 Patients treated with RECELL System globally VALENCIA, Calif. and...
Avita logo.jpg
AVITA Therapeutics Appoints Kathy McGee as Chief Operating Officer
December 01, 2020 08:00 ET | AVITA Medical
VALENCIA, Calif, and MELBOURNE, Australia, Dec. 01, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing...
Avita logo.jpg
AVITA Therapeutics to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 18, 2020 16:01 ET | AVITA Medical
VALENCIA, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...
Avita logo.jpg
AVITA Therapeutics Reports First Quarter 2021 Financial Results
November 10, 2020 16:01 ET | AVITA Medical
VALENCIA, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...
Avita logo.jpg
AVITA Therapeutics, Inc.: Results of 2020 Annual Meeting of Shareholders
November 10, 2020 08:00 ET | AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 10, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and...
Avita logo.jpg
AVITA Therapeutics and the Houston Methodist Research Institute Enter into Collaboration to Explore Novel Approaches for Skin Rejuvenation
November 09, 2020 08:00 ET | AVITA Medical
Preclinical research will pair AVITA Therapeutics’ Spray-On Skin™ Cells with Houston Methodist Research Institute’s technologies to reverse cellular aging AVITA Therapeutics secures exclusive...
Avita logo.jpg
AVITA Therapeutics, Inc. Announces Executive Change
November 05, 2020 22:30 ET | AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 05, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing...
Avita logo.jpg
Avita Therapeutics, Inc. Announces Correction of Time for the Adjourned 2020 Annual Stockholder Meeting
November 05, 2020 07:46 ET | AVITA Medical
VALENCIA, Calif, and MELBOURNE, Australia, Nov. 05, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing...